JLPC(SH:600513)2016-04-21 16:00Financial Performance - Operating revenue for the year-to-date was CNY 157,047,216.48, down 8.50% year-on-year[6] - Net profit attributable to shareholders of the listed company was CNY 12,487,396.01, an increase of 9.45% compared to the same period last year[6] - The weighted average return on equity decreased by 1 percentage point to 1.6%[6] - Basic earnings per share remained at CNY 0.07[6] - Total operating revenue for Q1 2016 was CNY 157,047,216.48, a decrease of 8.5% compared to CNY 171,626,978.30 in the same period last year[24] - Total operating costs for Q1 2016 were CNY 143,019,880.62, down 10.1% from CNY 159,185,413.08 year-over-year[24] - Net profit for Q1 2016 reached CNY 12,457,712.34, an increase of 9.4% compared to CNY 11,388,830.99 in Q1 2015[25] - Total comprehensive income attributable to the parent company was CNY 12,487,396.01, an increase from CNY 11,408,968.95 in the previous period, reflecting a growth of approximately 9.4%[26] - Operating profit for Q1 2016 was CNY 14,812,248.79, reflecting a slight increase from CNY 13,841,479.54 in the same quarter last year[25] Assets and Liabilities - Total assets at the end of the reporting period were CNY 992,502,203.36, a decrease of 0.80% compared to the end of the previous year[6] - The company's current assets totaled CNY 693,718,876.17, down from CNY 719,809,355.89 at the start of the year, reflecting a decrease of approximately 3.6%[16] - Cash and cash equivalents decreased to CNY 393,957,680.23 from CNY 406,741,479.80, representing a decline of about 3.4%[16] - Accounts receivable slightly decreased to CNY 166,868,563.07 from CNY 168,167,669.62, a reduction of approximately 0.8%[16] - Inventory increased to CNY 52,595,601.24 from CNY 51,371,056.33, marking an increase of about 2.4%[16] - Total liabilities decreased to CNY 205,170,209.30 from CNY 225,662,360.13, a decline of approximately 9.1%[18] - The company's equity attributable to shareholders rose to CNY 786,636,683.41 from CNY 774,149,287.40, an increase of about 1.6%[18] - The non-current assets totaled CNY 298,783,327.19, up from CNY 280,727,285.97, reflecting an increase of about 6.4%[17] Shareholder Information - The total number of shareholders at the end of the reporting period was 19,063[9] - The largest shareholder, Jiangsu Lianhuan Pharmaceutical Group Co., Ltd., held 37.09% of the shares[9] - The company increased its shareholding by 170,902 shares, representing 0.1% of the total share capital, on August 26, 2015[13] Cash Flow - The company reported a net cash flow from operating activities of -CNY 9,625,797.30, a decline of 26.27% year-on-year[6] - The company reported a net cash flow from operating activities of CNY -9,625,797.30, worsening from CNY -7,623,343.75 in the previous year[28] - Cash and cash equivalents at the end of the period totaled CNY 393,957,680.23, down from CNY 406,741,479.80 at the beginning of the period[28] - The company raised CNY 31,500,000.00 through borrowings, compared to CNY 54,500,000.00 in the previous period, indicating a decrease of approximately 42.2%[28] Government and Regulatory Compliance - Government subsidies recognized in the current period amounted to CNY 210,000.00[6] - The company committed to cash compensation to shareholders if the actual profits of the acquired assets in 2013, 2014, and 2015 fall short of the promised net profit[11] - The company will not engage in any business that competes with its subsidiaries during the period of being the controlling shareholder[12] - The company guarantees the establishment of an independent financial department and accounting system for its subsidiary[12] - The company will ensure that its subsidiary has independent assets and operational capabilities to sustain market activities[12]